Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

362 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2.
Wines BD, Kurtovic L, Trist HM, Esparon S, Lopez E, Chappin K, Chan LJ, Mordant FL, Lee WS, Gherardin NA, Patel SK, Hartley GE, Pymm P, Cooney JP, Beeson JG, Godfrey DI, Burrell LM, van Zelm MC, Wheatley AK, Chung AW, Tham WH, Subbarao K, Kent SJ, Hogarth PM. Wines BD, et al. Among authors: burrell lm. Front Immunol. 2022 Jul 28;13:889372. doi: 10.3389/fimmu.2022.889372. eCollection 2022. Front Immunol. 2022. PMID: 35967361 Free PMC article.
Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial.
McGree JM, Hockham C, Kotwal S, Wilcox A, Bassi A, Pollock C, Burrell LM, Snelling T, Jha V, Jardine M, Jones M; CLARITY Trial Steering Committee. McGree JM, et al. Among authors: burrell lm. Trials. 2022 Apr 27;23(1):361. doi: 10.1186/s13063-022-06167-2. Trials. 2022. PMID: 35477480 Free PMC article. Clinical Trial.
A distinct cognitive profile in individuals with 3q29 deletion syndrome.
Klaiman C, White SP, Saulnier C, Murphy M, Burrell L, Cubells J, Walker E; Emory 3q29 Project, Mulle JG. Klaiman C, et al. Among authors: burrell l. J Intellect Disabil Res. 2022 Mar 16. doi: 10.1111/jir.12919. Online ahead of print. J Intellect Disabil Res. 2022. PMID: 35297118
Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial.
Hockham C, Kotwal S, Wilcox A, Bassi A, McGree J, Pollock C, Burrell LM, Bathla N, Kunigari M, Rathore V, John M, Lin E, Jenkins C, Ritchie A, McLachlan A, Snelling T, Jones M, Jha V, Jardine M; CLARITY Investigators. Hockham C, et al. Among authors: burrell lm. Trials. 2021 Aug 28;22(1):573. doi: 10.1186/s13063-021-05521-0. Trials. 2021. PMID: 34454580 Free PMC article.
Erratum to "Second Consensus on Treatment of Patients Recently Diagnosed with Mild Hypertension and Low Cardiovascular Risk". [YMCD 45/10 (October 2020) 100653].
Morales-Salinas A, Olsen MH, Kones R, Kario K, Wang JG, Beilin L, Weber MA, Yano Y, Burrell LM, Orias M, Dzudie A, Lavie C, Ventura H, Sundström J, de Simone G, Coca A, Rumana U, Marrugat J. Morales-Salinas A, et al. Among authors: burrell lm. Curr Probl Cardiol. 2021 Dec;46(12):100877. doi: 10.1016/j.cpcardiol.2021.100877. Epub 2021 Jun 17. Curr Probl Cardiol. 2021. PMID: 34148707 No abstract available.
362 results